Recordati reported EUR391.38M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Almirall EUR 337.77M 14.83M Dec/2025
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Hikma Pharmaceutical USD 217M 19M Dec/2025
Orion EUR 199.3M 38.4M Mar/2026
Sanofi EUR 6.35B 806M Jun/2026